1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

Novus Biologicals Launches New HIF Prolyl Hydroxylase Antibody

Novus Biologicals, an international supplier of antibodies, biological products and materials to various scientific sectors, have launched a new HIF Prolyl Hydroxylase antibody for use in research

FOR IMMEDIATE RELEASE

 
PRLog (Press Release) - Feb. 2, 2010 - Cambridge, England (January 29, 2010) - Novus Biologicals, an international supplier of antibodies, biological products and materials to various scientific sectors, have launched a new HIF Prolyl Hydroxylase antibody for use in research.

Novus Biologicals, a leading supplier of hypoxia-inducible factor (HIF) antibodies, recently launched a new HIF Prolyl Hydroxylase 3 antibody (catalog #: NBP1-22574).  HIF prolyl hydroxylase 3 is a prolyl hydroxylase that specifically modifies HIF1-alpha. Classic prolyl hydroxylases are found in the endoplasmic reticulum and modify collagen; whereas HIF is an intracellular protein and the HPH sites do not resemble those modifying collagen. HIF is a transcriptional complex that plays a critical role in oxygen homeostasis. HPH is an essential component of the pathway through which cells sense oxygen. In the presence of oxygen, HPHs convert specific prolyl residues in HIF1-alpha to hydroxyproline, leading to HIF1-alpha destruction. Low oxygen levels, sensed at the cellular level, cause the HIF conversion to be reduced so that HIF is stable and there is increased angiogenesis.

Novus' newly released mouse monoclonal anti- HIF Prolyl Hydroxylase 3 antibody (clone A1.10) was made to the full length human PHD3 protein purified from Sf9 insect cells.  It is protein G purified and was QC tested in Western blot on PHD3 overexpression lysate resulting in a clear band at 27kDa.

Researchers interested in HIF Prolyl Hydroxylase 3 antibodies can use Novus' bioinformatic tool, the Novus Explorer, to investigate relationships between HIF Prolyl Hydroxylase 3 and other genes, diseases and pathways.

To find out more about Novus Biologicals and their antibody database,visit their website at http://www.novusbio.com/ or call +44 (0)1223 426001.

# # #

Novus Biologicals is an international scientific company, helping to accelerate the advancement of scientific discoveries by developing and commercialising new products in scientific and biological fields. By promoting and commercialising unique biological materials and products to the biological research community, Novus plays an important part in helping to advance international biological research practices. Novus is also constantly monitoring emerging scientific trends and strives to supply products for their advancement.

--- End ---

Click to Share

Contact Email:
***@novusbio.com
Source:Jhon carlos
Phone:1223 426001
Address:12 Cambridge Science Park
Zip:CB4 0FQ
City/Town:Cambridgeshire - England - United Kingdom
Industry:Health
Tags:, , , ,
Shortcut:http://prlog.org/10514782
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Upcoming Press Releases...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
8.4K1.9K2.6K
Click to Share